Recombinant Il-18 Antibodies Useful In Treatment Of Il-18 Mediated Disorders


The full document isn't yet available to us from the patent office.


Chimeric, humanized and other IL-18 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.


Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Aug 27, 2008
  • Application: Mar 17, 2000
    EP EP 08157217 A
  • Priority: Mar 17, 2000
    EP EP 00918152 A
  • Priority: Mar 19, 1999
    US US 12529999 P

Download Citation

Sign in to the Lens